{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:43Z","timestamp":1791561283552,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jctube.2021.100224","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T14:11:42Z","timestamp":1613916702000},"page":"100224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Overview on coinfection of HTLV-1 and tuberculosis: Mini-review"],"prefix":"10.1016","volume":"23","author":[{"given":"Masoud","family":"Keikha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Karbalaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2021.100224_b0005","unstructured":"Organization WH. Global tuberculosis report 2020. Global tuberculosis report 2020.2020."},{"key":"10.1016\/j.jctube.2021.100224_b0010","doi-asserted-by":"crossref","first-page":"100632","DOI":"10.1016\/j.mgene.2019.100632","article-title":"The mystery of tuberculosis pathogenesis from the perspective of T regulatory cells","volume":"23","author":"Keikha","year":"2020","journal-title":"Meta Gene"},{"key":"10.1016\/j.jctube.2021.100224_b0015","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"Organization","year":"2018"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14760584.2018.1406309","article-title":"Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?","volume":"17","author":"Khademi","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jctube.2021.100224_b0025","doi-asserted-by":"crossref","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016;13:e1002152.","DOI":"10.1371\/journal.pmed.1002152"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-014-0103-7","article-title":"Interaction of pattern recognition receptors with Mycobacterium tuberculosis","volume":"35","author":"Mortaz","year":"2015","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.jctube.2021.100224_b0035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/eji.201545843","article-title":"Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB","volume":"46","author":"Toulza","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jctube.2021.100224_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/814943","article-title":"Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection","volume":"2011","author":"Ahmad","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000439275","article-title":"Alveolar epithelial cells in Mycobacterium tuberculosis infection: active players or innocent bystanders?","volume":"8","author":"Scordo","year":"2016","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jctube.2021.100224_b0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.qai.0000174252.73516.7a","article-title":"Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study","volume":"40","author":"Marinho","year":"2005","journal-title":"JAIDS J Acquired Immun Def Syndromes"},{"key":"10.1016\/j.jctube.2021.100224_b0055","doi-asserted-by":"crossref","unstructured":"Montes M, Sanchez C, Verdonck K, Lake JE, Gonzalez E, Lopez G, et al. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 2009;3:e456.","DOI":"10.1371\/journal.pntd.0000456"},{"key":"10.1016\/j.jctube.2021.100224_b0060","doi-asserted-by":"crossref","unstructured":"Azakami K, Sato T, Araya N, Utsunomiya A, Kubota R, Suzuki K, et al. Severe loss of invariant NKT cells exhibiting anti\u2013HTLV-1 activity in patients with HTLV-1\u2013associated disorders. Blood J Am Soc Hematol 2009;114:3208\u201315.","DOI":"10.1182\/blood-2009-02-203042"},{"key":"10.1016\/j.jctube.2021.100224_b0065","doi-asserted-by":"crossref","unstructured":"Paquin-Proulx D, Greenspun BC, Costa EA, Segurado AC, Kallas EG, Nixon DF, et al. MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications. PLoS One 2017;12:e0175345.","DOI":"10.1371\/journal.pone.0175345"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1428-z","article-title":"Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil","volume":"16","author":"Grassi","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jctube.2021.100224_b0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijtb.2018.08.007","article-title":"What is the role of\u201c T reg Cells\u201d in tuberculosis pathogenesis?","volume":"65","author":"Keikha","year":"2018","journal-title":"Ind J Tuberculosis"},{"issue":"12","key":"10.1016\/j.jctube.2021.100224_b0080","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci"},{"issue":"1-2","key":"10.1016\/j.jctube.2021.100224_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","article-title":"The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran","volume":"250","author":"Rafatpanah","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jctube.2021.100224_b0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biopha.2018.10.139","article-title":"Molecular targeting for treatment of human T-lymphotropic virus type 1 infection","volume":"109","author":"Soltani","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jctube.2021.100224_b0095","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3389\/fmicb.2018.03069","article-title":"Molecular pathology of HTLV-1","volume":"9","author":"Bertazzoni","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: persistence and pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.jctube.2021.100224_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v8030074","article-title":"Molecular mechanisms of HTLV-1 cell-to-cell transmission","volume":"8","author":"Gross","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jctube.2021.100224_b0110","first-page":"31","article-title":"Co-infection of tuberculosis and HIV\/HTLV retroviruses: frequency and prognosis among patients admitted in a Brazilian Hospital","volume":"1","author":"Pedral-Sampaio","year":"1997","journal-title":"Braz J Infect Dis Official Publ Braz Soc Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-12-199","article-title":"Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis","volume":"12","author":"Bastos","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jctube.2021.100224_b0120","first-page":"1066","article-title":"HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru","volume":"11","author":"Verdonck","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.jctube.2021.100224_b0125","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.2910420605","article-title":"Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan","volume":"42","author":"Tachibana","year":"1988","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jctube.2021.100224_b0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/CVI.13.5.547-552.2006","article-title":"Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens","volume":"13","author":"Mascarenhas","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jctube.2021.100224_b0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tube.2017.10.004","article-title":"Impaired TNF, IL-1\u03b2, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals","volume":"108","author":"Carvalho","year":"2018","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.jctube.2021.100224_b0140","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/v10120691","article-title":"Cytokine networks dysregulation during HTLV-1 infection and associated diseases","volume":"10","author":"Futsch","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jctube.2021.100224_b0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","article-title":"Molecular hallmarks of adult T cell leukemia","volume":"3","author":"Yamagishi","year":"2012","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.jctube.2021.100224_b0150","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/aid.2015.0340","article-title":"Association of tuberculosis status with neurologic disease and immune response in HTLV-1 infection","volume":"33","author":"Souza","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.jctube.2021.100224_b0155","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/jmv.23307","article-title":"Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement","volume":"84","author":"Kawabata","year":"2012","journal-title":"J Med Virol"},{"issue":"8569","key":"10.1016\/j.jctube.2021.100224_b0160","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","article-title":"T-lymphocyte alveolitis in HTLV-I-associated myelopathy","volume":"330","author":"Sugimoto","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jctube.2021.100224_b0165","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3389\/fmicb.2018.01879","article-title":"Human T lymphotropic virus and pulmonary diseases","volume":"9","author":"Dias","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jctube.2021.100224_b0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1742-4690-5-86","article-title":"Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules","volume":"5","author":"Teruya","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.jctube.2021.100224_b0175","first-page":"1519","article-title":"Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis","volume":"13","author":"de Lourdes","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.jctube.2021.100224_b0180","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/crad.2001.0677","article-title":"HTLV-1-associated bronchopneumonopathy (HAB): CT\u2013pathological correlation","volume":"56","author":"Tateishi","year":"2001","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jctube.2021.100224_b0185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-015-1002-0","article-title":"High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease","volume":"15","author":"Honarbakhsh","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"39","key":"10.1016\/j.jctube.2021.100224_b0190","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","article-title":"Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy","volume":"24","author":"Taylor","year":"2005","journal-title":"Oncogene"},{"issue":"6-7","key":"10.1016\/j.jctube.2021.100224_b0195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","article-title":"Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity","volume":"20","author":"Starling","year":"2015","journal-title":"Biomarkers"},{"key":"10.1016\/j.jctube.2021.100224_b0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.qai.0000557949.06002.e2","article-title":"A-109 A novel multi-cytokine inhibitory strategy in treating HTLV-1 diseases","volume":"81","author":"Tagaya","year":"2019","journal-title":"JAIDS J Acquired Immun Deficiency Syndromes"},{"issue":"5","key":"10.1016\/j.jctube.2021.100224_b0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/pathogens9050342","article-title":"Antiretroviral therapy in HTLV-1 Infection: an updated overview","volume":"9","author":"Marino-Merlo","year":"2020","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.jctube.2021.100224_b0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S1413-86702004000300004","article-title":"Efficacy and safety of efavirenz in HIV patients on rifampin for tuberculosis","volume":"8","author":"Pedral-Sampaio","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jctube.2021.100224_b0215","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves DU, Proietti FA, Ribas JGR, Ara\u00fajo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 2010;23:577\u201389.","DOI":"10.1128\/CMR.00063-09"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:38:08Z","timestamp":1762501088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579421000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":43,"alternative-id":["S2405579421000139"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100224","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview on coinfection of HTLV-1 and tuberculosis: Mini-review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100224"}}